New method for imaging cellular processes at the nanoscale
Dynamic nanoscale cellular imaging via time-resolved cryo-vitrification
This study is creating a new tool to help scientists see how cells react to different substances in real-time by freezing them for super-clear images, which could help us learn more about how cells work and interact with each other.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10855414 on NIH RePORTER |
What this research studies
This research aims to develop a groundbreaking tool that allows scientists to stimulate biological cells with various compounds and then freeze them for high-resolution imaging. By using a technique called Vitrification Experiment Resolved In Time After Stimulation (VERITAS), researchers will be able to capture rapid cellular changes that occur in response to stimuli, which are often missed by traditional microscopy. This innovative approach combines time-resolved cryo-vitrification with advanced imaging techniques to explore cellular dynamics in unprecedented detail. The findings could enhance our understanding of critical cellular functions and interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions that involve rapid cellular changes, such as certain cancers or autoimmune diseases.
Not a fit: Patients with stable, chronic conditions that do not involve dynamic cellular processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in our understanding of cellular processes, potentially informing new treatments for various diseases.
How similar studies have performed: Other research has shown success with advanced imaging techniques, but this specific approach using time-resolved cryo-vitrification is novel and untested.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Prigozhin, Maxim — Harvard University
- Study coordinator: Prigozhin, Maxim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.